Bone Therapeutics Company
%20.jpg)
Bone Therapeutics is a leading international biopharmaceutical company focused on innovative cell therapy products for the treatment of bone diseases. Utilizing the Company's unique knowledge of the bone/joint physiology and long-standing expertise in cell therapy and cell transplantation, Bone Therapeutics has created a fully integrated business with an advanced product pipeline comprising novel bone cell products, tailored in-house production methods, and minimally invasive treatment techniques.
Founded Date:
2006-01-01
Total Funding:
€49.3M
Investor Type:
For Profit
Employee Number:
51-100
Funding Status:
IPO
Technology:
P4 Medicine
Last Funding Type:
Post-IPO Equity
Investors Number:
3
Industry:
Biotechnology, Health Care, Science and Engineering
Headquarters:
Gosselies, Hainaut, Belgium
Estimated Revenue:
Less than $1M